Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Seelos Therapeutics Inc (SEEL)  
$0.11 0.00 (0.00%) as of 4:30 Mon 11/27


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 102,230,000
Market Cap: 10.87(M)
Last Volume: 10,264,973 Avg Vol: 10,237,079
52 Week Range: $0.1063 - $1.64
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Seelos Therapeutics is a clinical-stage biopharmaceutical company focused on the development of products that address unmet needs in Central Nervous System disorders and other disorders. Co.'s primary programs are SLS-002 for the potential treatment of Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder and SLS-005 for the potential treatment of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia. Co. is also developing several preclinical programs, including SLS-004, SLS-006, and SLS-007 for the potential treatment of Parkinson's Disease, SLS-010 in narcolepsy and related disorders, and SLS-012, an injectable therapy for post-operative pain management.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 158,757 158,757
Total Buy Value $0 $0 $200,222 $200,222
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 395
  Page 4 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wierenga Wendall D Director   –       •      –    2014-10-22 4 B $1.52 $30,364 D/D 20,000 20,000 2.39     -
   Ray Rusty Director   –       •      –    2014-10-22 4 B $1.50 $5,250 D/D 3,500 32,352 2.39     -
   Pascoe Richard W Chief Executive Officer   •       •      –    2014-10-22 4 B $1.51 $18,120 D/D 12,000 37,000 2.81     -
   Oppenheim Leonard A Director   –       •      –    2014-01-03 4 S $2.49 $37,928 D/D (15,212) 20,449     -
   Pascoe Richard W Chief Executive Officer   •       •      –    2013-12-30 4 GD $0.00 $0 D/D 10,000 25,000     -
   Xanthopoulos Kleanthis G Director   –       •      –    2013-12-26 4 AS $2.55 $43,819 I/I (17,184) 55,735     -
   Xanthopoulos Kleanthis G Director   –       •      –    2013-06-21 4 AS $2.52 $7,217 I/I (2,864) 72,919     -
   Martin Steven Robert Senior VP & CFO   •       –      –    2013-05-23 4 B $2.85 $57,000 D/D 20,000 20,000 2.74     -
   Pascoe Richard W Chief Executive Officer   •       •      –    2013-05-23 4 B $2.85 $99,750 D/D 35,000 35,000 2.81     -
   Ray Rusty Director   –       •      –    2013-05-23 4 B $2.85 $14,250 D/D 5,000 28,852 2.39     -
   Xanthopoulos Kleanthis G Director   –       •      –    2013-05-21 4 AS $3.36 $9,613 I/I (2,864) 75,783     -
   Xanthopoulos Kleanthis G Director   –       •      –    2013-04-22 4 AS $2.63 $7,524 I/I (2,864) 78,647     -
   Xanthopoulos Kleanthis G Director   –       •      –    2013-03-21 4 AS $2.50 $7,160 I/I (2,864) 81,511     -
   Xanthopoulos Kleanthis G Director   –       •      –    2012-09-28 4 AS $3.25 $10,158 I/I (3,125) 84,375     -
   Damaj Bassam President and CEO   •       •      –    2012-08-23 4 A $0.00 $0 D/D 249,002 1,610,987     -
   Damaj Bassam President and CEO   •       •      –    2012-08-21 4 B $2.77 $2,105 D/D 760 1,611,747 2.73     -
   Cox Edward M. VP of Corporate Development   •       –      –    2012-08-20 4 B $2.73 $4,091 D/D 1,500 158,541 2.66     -
   Damaj Bassam President and CEO   •       •      –    2012-08-20 4 B $2.69 $4,034 D/D 1,500 1,361,985 2.73     -
   Ray Rusty Director   –       •      –    2012-08-17 4 B $2.81 $11,244 D/D 4,000 23,852 2.39     -
   Xanthopoulos Kleanthis G Director   –       •      –    2012-08-15 4 AS $3.01 $37,684 D/D (12,500) 87,500     -
   Ray Rusty Director   –       •      –    2012-01-03 4 A $5.13 $14,282 D/D 2,784 19,852     -
   Gillespie Deirdre Director   –       •      –    2012-01-03 4 A $5.13 $14,282 D/D 2,784 15,433     -
   Oppenheim Leonard A Director   –       •      –    2012-01-03 4 A $5.13 $14,282 D/D 2,784 33,995     -
   Esber Henry Jemil Director   –       •      –    2012-01-03 4 A $5.13 $12,851 D/D 2,505 609,217     -
   Xanthopoulos Kleanthis G Director   –       •      –    2011-11-17 4 A $0.00 $0 D/D 100,000 100,000     -
  395 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us